Loading patent…
AssigneesScohia Pharma, Inc., National University Corporation Hokkaido University
InventorsJun SUGAMA, Yusuke MORITOH, Masanori WATANABE, Fumihiko HATTANDA, Takuro KAWAMURA, Saori NISHIO
Estimating the term…
A medicament containing an enteropeptidase inhibitor as an active ingredient, for preventing and/or treating polycystic kidney disease; a method for preventing and/or treating polycystic kidney disease, containing administering an effective amount of an enteropeptidase inhibitor to a subject requiring the administration are provided as some embodiments of the present invention. They are highly effective in suppressing and/or improving cyst formation, or suppressing and/or improving kidney volume increase.
A method for suppressing and/or improving cyst formation, or suppressing and/or improving kidney volume increase based on the suppression and/or improvement of cyst formation, in a subject suffering from polycystic kidney disease, comprising administering an effective amount of an enteropeptidase inhibitor to the subject.
A method for preventing and/or treating polycystic kidney disease, comprising administering an effective amount of an enteropeptidase inhibitor to a subject requiring the administration.
Dependencies are inferred from the claim text.